ACTINIUM PHARMACEUTICALS, INC. (ATNM) Free cash flow 2016–2025
ACTINIUM PHARMACEUTICALS, INC. (ATNM) annual free cash flow history — operating cash flow minus capital expenditures, per SEC filings.
-$24.7MFY2025 · since FY2016: -$20.8M → -$24.7M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$24.7M | +25.4% |
| FY2024 | -$33.1M | +30.3% |
| FY2023 | -$47.5M | -673.7% |
| FY2022 | $8.3M | +139.4% |
| FY2021 | -$21.0M | +4.0% |
| FY2020 | -$21.9M | -1.6% |
| FY2019 | -$21.5M | -4.2% |
| FY2018 | -$20.7M | +4.2% |
| FY2017 | -$21.6M | -3.5% |
| FY2016 | -$20.8M | — |
Free cash flow = reported operating cash flow − reported capital expenditures for the same fiscal year.
Source: SEC XBRL filings · For reference only · Not investment advice